LifeMD, Inc. (LFMD)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$4.50
-1.53%
Mkt Cap $219.24M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 9, 2026 | $45.82M | $46.87M | +2.28% | -$0.01 | -$0.04 | -300.00% | — | — |
| Q4 2025 Nov 17, 2025 | $48.57M | $60.17M | +23.88% | -$0.06 | -$0.10 | -66.67% | — | — |
| Q3 2025 Aug 4, 2025 | $66.31M | $62.22M | -6.18% | $0.18 | -$0.05 | -125.96% | — | — |
| Q2 2025 May 6, 2025 | $65.46M | $65.70M | +0.36% | -$0.04 | $0.01 | +125.00% | — | — |
| Q1 2025 Mar 10, 2025 | $59.62M | $64.25M | +7.77% | -$0.04 | -$0.02 | +50.00% | — | — |
| Q4 2024 Nov 7, 2024 | $57.71M | $53.27M | -7.69% | -$0.12 | -$0.14 | -16.67% | — | — |
| Q3 2024 Aug 7, 2024 | $48.25M | $50.66M | +5.00% | -$0.12 | -$0.19 | -58.33% | — | — |
| Q2 2024 May 8, 2024 | $42.54M | $44.14M | +3.77% | -$0.15 | -$0.19 | -26.67% | — | — |
| Q1 2024 Mar 11, 2024 | $40.49M | $44.86M | +10.79% | -$0.14 | -$0.12 | +14.29% | — | — |
| Q4 2023 Nov 8, 2023 | $40.49M | $38.61M | -4.63% | -$0.15 | -$0.20 | -33.33% | — | — |
| Q3 2023 Aug 9, 2023 | $35.16M | $35.95M | +2.24% | -$0.10 | -$0.23 | -130.00% | — | — |
| Q2 2023 May 12, 2023 | $30.80M | $33.13M | +7.55% | -$0.16 | -$0.15 | +6.25% | — | — |
| Q1 2023 Mar 22, 2023 | $33.60M | $28.12M | -16.31% | -$0.18 | $0.02 | +111.11% | — | — |
| Q4 2022 Nov 10, 2022 | $31.85M | $31.41M | -1.36% | -$0.27 | -$0.03 | +88.89% | — | — |
| Q3 2022 Aug 11, 2022 | $31.31M | $30.46M | -2.73% | -$0.23 | -$0.22 | +4.35% | — | — |
| Q2 2022 May 13, 2022 | $31.53M | $29.04M | -7.88% | -$0.26 | -$0.25 | +3.85% | — | — |
| Q1 2022 Mar 7, 2022 | $27.46M | $27.42M | -0.16% | -$0.39 | -$0.29 | +25.64% | — | — |
| Q4 2021 Nov 10, 2021 | $31.57M | $24.95M | -20.97% | -$0.49 | -$0.36 | +26.53% | — | — |
| Q3 2021 Aug 12, 2021 | $21.88M | $22.31M | +1.98% | -$0.53 | -$0.64 | -20.75% | — | — |
| Q2 2021 May 13, 2021 | $23.63M | $18.20M | -22.99% | -$0.67 | -$0.47 | +29.85% | — | — |